Viewing Study NCT02582658


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-04-08 @ 7:26 AM
Study NCT ID: NCT02582658
Status: COMPLETED
Last Update Posted: 2019-06-05
First Post: 2015-10-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10-06
Start Date Type: None
Primary Completion Date: 2017-01-12
Primary Completion Date Type: ACTUAL
Completion Date: 2017-01-12
Completion Date Type: ACTUAL
First Submit Date: 2015-10-20
First Submit QC Date: None
Study First Post Date: 2015-10-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-01-08
Results First Submit QC Date: None
Results First Post Date: 2019-06-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-02-28
Last Update Post Date: 2019-06-05
Last Update Post Date Type: ACTUAL